Antithrombotic Forum-3 Management and Anticoagulation Therapy of Patients with Atrial Fibrillation 源自亚洲，为“凝”而来
|
10:00-12:10 多功能B |
|---|
|
上半场 |
||||
|---|---|---|---|---|
| 主持 Moderators | 项美香 Meixiang XIANG, 杨跃进 Yuejin YANG | |||
| 讨论嘉宾 Discussants | 郑武扬 Wuyang ZHENG, 黎励文 Liwen LI, 丰明俊 Mingjun FENG | |||
|
10:00-10:02 |
嘉宾致辞 Opening Remarks |
王建安Jianan WANG |
||
|
10:02-10:05 |
主席开场 Opening Remarks |
项美香Meixiang XIANG 杨跃进Yuejin YANG |
||
|
10:25-10:45 |
《老年心房颤动诊治中国专家共识（2024）》解读 Interpretation of Chinese Expert Consensus on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly (2024) |
陈柯萍 Keping CHEN | ||
|
10:45-10:55 |
从国内外指南共识看房颤抗凝治疗要点 Main Points of Anticoagulation Treatment of Atrial Fibrillation from the Consensus of Domestic and Foreign Guidelines |
张必祺 Biqi ZHANG | ||
|
10:55-11:00 |
总结 1 Summary |
项美香Meixiang XIANG |
||
|
10:55-11:00 |
讨论 Discussion |
|||
|
11:00-11:05 |
总结 1 Summary |
杨跃进Yuejin YANG |
||
|
下半场 |
||||
|---|---|---|---|---|
| 主持 Moderators | 张力 Li ZHANG, 谭宁 Ning TAN | |||
| 讨论嘉宾 Discussants | 张庆 Qing ZHANG, 陈晓曙 Xiaoshu CHEN, 袁红 Hong YUAN | |||
|
11:00-11:05 |
主席开场 Opening Remarks |
张力Li ZHANG 谭宁Ning TAN |
||
|
11:05-11:25 |
探讨房颤合并冠心病患者的抗栓治疗策略 Investigation of the Antithrombotic Treatment Strategy of Patients with Atrial Fibrillation Complicated with Coronary Heart Disease |
丁亚辉 Yahui DING | ||
|
11:25-11:45 |
NOAC剂量规范的深层逻辑和价值解析 Deep Logic and Value Analysis of NOAC Dose Specification |
陈松文 Songwen CHEN | ||
|
11:45-11:55 |
讨论 Discussion |
|||
|
11:55-12:00 |
总结 Summary |
张力Li ZHANG 谭宁Ning TAN |
||